HOUSTON, Texas—Forward Science was founded in 2012 with the mission to change lives through innovative, cost-effective products. In March, Forward Science’s flagship device, OralID, will celebrate 10 years since its FDA clearance.
OralID is a battery-operated, hand-held oral cancer screening device that uses fluorescence technology to provide clinicians an aid in visualization of oral mucosal abnormalities, such as oral cancer and pre-cancer. Over the last decade, tens of thousands of clinicians have used OralID globally. In partnership with these dental offices and clinicians, countless lesions and abnormalities have been discovered with an OralID screening.
Forward Science prides itself on providing innovative technologies to clinicians. Throughout the last decade, OralID has received several recognitions highlighting these innovations, such as the Best New Preventative Product, Product of the Year and Top Oral Cancer Screening Device every year OralID has been on the market.
For more information, visit Forwardscience.com.